NCT07196735 Bio-electrical Impedance Analysis in Patients With Functional Dyspepsia
| NCT ID | NCT07196735 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitair Ziekenhuis Brussel |
| Condition | Functional Dyspepsia |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-09-18 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2025-09-18 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of this study is to compare the BIA parameters, including Phase Angle, Fat Free Mass and Fat Mass, between women with functional dyspepsia and healthy women. All woman will undergo a bio-electrical impedance monitoring for this.
Eligibility Criteria
Inclusion Criteria: * Women aged 18 - 75 years * Fulfilling the ROME IV criteria for functional dyspepsia (for FD patients) * FD unexplained by upper GI endoscopy during the past 12 months (mild gastritis allowed) (for FD patients). Exclusion Criteria: * Clinical suspicion of an organic disorder different from FD (patients can be included when this disorder had been excluded); * Abnormality on upper GI endoscopy other than mild gastritis (for FD patients). * Known reflux oesophagitis Los Angeles grade C or D, known Barrett oesophagus, peptic stricture. * H pylori infection, unless treated at least 6 months before; * Known inflammatory bowel disorder; * Known major intestinal motility disorder; * Alcohol (defined as more than 14 U per week) or other substance abuse; * Active psychiatric disorder; * Known systemic or auto-immune disorder with implication for the GI system; * Prior abdominal surgery (with the exception of cholecystectomy or ap-pendectomy); * Any prior diagnosis of cancer other than basocellular carcinoma; * Current chemotherapy; * History of gastro-enteritis in the past 12 weeks; * Dietary supplements unless taken at a stable dose for more than 12 weeks; * Treatment with neuromodulators (one neuromodulator taken at a sta-ble dose for more than 12 weeks is allowed); * Treatment with PPI's during the past 8 weeks * Pregnancy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07196735 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 75 Years, studying Functional Dyspepsia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07196735 currently recruiting?
Yes, NCT07196735 is actively recruiting participants. Contact the research team at sebastien.kindt@uzbrussel.be for enrollment information.
Where is the NCT07196735 trial being conducted?
This trial is being conducted at Brussels, Belgium.
Who is sponsoring the NCT07196735 clinical trial?
NCT07196735 is sponsored by Universitair Ziekenhuis Brussel. The trial plans to enroll 40 participants.